Harnessing transposable elements for cancer therapy

Transposable elements (TEs) can move within the genome and can have a significant role in cancer development. Shah et al. recently identified that TEs have regulatory potentials and that tumor-specific TE–gene chimeric events that produce new isoforms of proteins could serve as universal cancer biomarkers and targets for cancer immunotherapy.